[go: up one dir, main page]

FI20011908A0 - Procedure for detection of gastric cancer - Google Patents

Procedure for detection of gastric cancer

Info

Publication number
FI20011908A0
FI20011908A0 FI20011908A FI20011908A FI20011908A0 FI 20011908 A0 FI20011908 A0 FI 20011908A0 FI 20011908 A FI20011908 A FI 20011908A FI 20011908 A FI20011908 A FI 20011908A FI 20011908 A0 FI20011908 A0 FI 20011908A0
Authority
FI
Finland
Prior art keywords
individual
cellular fibronectin
gastric
concentration
value
Prior art date
Application number
FI20011908A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20011908A7 (en
FI20011908L (en
Inventor
Osmo Suovaniemi
Matti Haerkoenen
Pentti Sipponen
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Priority to FI20011908A priority Critical patent/FI20011908L/en
Publication of FI20011908A0 publication Critical patent/FI20011908A0/en
Priority to PCT/FI2002/000773 priority patent/WO2003029826A1/en
Publication of FI20011908A7 publication Critical patent/FI20011908A7/en
Publication of FI20011908L publication Critical patent/FI20011908L/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/595—Gastrins; Cholecystokinins [CCK]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A method for detecting or screening cancer in an individual is described, which method comprises determining the gastritis phenotype of the gastric mucosa of the said individual, determining the cellular fibronectin concentration in a sample such as a serum sample of said individual, selecting a cut−off value for cellular fibronectin, and comparing the cellular fibronectin concentration to the selected cutoff value. A combination of a condition of atrophic gastritis and a concentration of cellular fibronectin above the selected cut­off value is then indicative of gastric cancer in said individual. The gastric phenotype of the gastric mucosa is determined by an analysis of the pepsinogen I and gastrin−17 levels in said individual.
FI20011908A 2001-09-28 2001-09-28 Method for detecting stomach cancer FI20011908L (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20011908A FI20011908L (en) 2001-09-28 2001-09-28 Method for detecting stomach cancer
PCT/FI2002/000773 WO2003029826A1 (en) 2001-09-28 2002-09-30 Method for detecting a cancer or precancerous condition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20011908A FI20011908L (en) 2001-09-28 2001-09-28 Method for detecting stomach cancer

Publications (3)

Publication Number Publication Date
FI20011908A0 true FI20011908A0 (en) 2001-09-28
FI20011908A7 FI20011908A7 (en) 2003-03-29
FI20011908L FI20011908L (en) 2003-03-29

Family

ID=8561972

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20011908A FI20011908L (en) 2001-09-28 2001-09-28 Method for detecting stomach cancer

Country Status (2)

Country Link
FI (1) FI20011908L (en)
WO (1) WO2003029826A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI119572B (en) * 2004-03-05 2008-12-31 Biohit Oyj Method for predicting the condition of the gastric mucosa
EA037027B1 (en) 2015-12-31 2021-01-27 Прогастрин Э Кансер С.А Р.Л. Use and method for preventing or treating gastric cancer using a composition comprising a monoclonal progastrin-binding antibody
CN111638366B (en) * 2020-04-30 2021-02-19 吉林省格瑞斯特生物技术有限公司 G-17, PGI and PGII combined detection device and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420012A (en) * 1989-05-08 1995-05-30 Locus Genex Oy Method for the detection of reactive conditions
FI97304C (en) * 1994-11-16 1996-11-25 Locus Genex Oy Procedure for screening cancer risk

Also Published As

Publication number Publication date
WO2003029826A1 (en) 2003-04-10
FI20011908A7 (en) 2003-03-29
FI20011908L (en) 2003-03-29

Similar Documents

Publication Publication Date Title
IL181132A0 (en) Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
EA200500355A1 (en) METHOD OF DETECTION, CHARACTERISTICS AND MONITORING OF HYDROCARBON DEPOSITS
BR9710836A (en) Analyte assay using particle marks
DK1141728T3 (en) Detection of kidney disease and treatment thereof
EP1381864A4 (en) Detection of candida
EP1379693A4 (en) Bio-barcodes based on oligonucleotide-modified particles
WO2006014351A3 (en) Exploring fluorophore microenvironments
CY1105313T1 (en) METHOD AND APPARATUS FOR MEASURING OXYGEN CONCENTRATION IN A CLOSED PURPOSE SPACE
ATE408829T1 (en) METHODS AND ASSAY KITS FOR DETECTING MONONUCLEAR CELL PHENOTYPES
ATE408813T1 (en) DETECTION OF ANALYTES
FI990992A0 (en) Procedure for determining the risk of peptic ulcer
AR058959A1 (en) METHODS TO MODULATE CELL PHONE RECEPTORS TO PREVENT OR REDUCE IMMFLAMATION
WO2003102015A3 (en) Method and apparatus for detecting and monitoring peptides, and peptides identified therewith
CY1105025T1 (en) LEPTIN ANALYSIS BASED ON ANG-2 EXPRESSION DETECTION
FI20011908A0 (en) Procedure for detection of gastric cancer
EP1336663A3 (en) Method to identify environmental contamination by detecting enteric viruses
DE60324698D1 (en) METHOD FOR DETECTING A RISK OF ACID-ASSOCIATED DISEASE IN A CUSTOM INDIVIDUAL
AU2003240673A1 (en) Method of detecting arcenic ions with indicator bacteria
IL189185A0 (en) Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
WO2000039581A3 (en) Test system for detecting different markers, and production and use thereof
AU2003288249A1 (en) Method for detecting the presence and determining the concentration of sulfur-free odorants in natural or combustible gas
WO2004016802A3 (en) Methods and apparatus for preparing and assaying biological samples to determine protein concentration
ATE274702T1 (en) USE OF DERIVATIZED REAGENTS IN CHEMILUMINESCENCE AND ELECTROCHEMILUMINESCENCE DETECTION METHODS
EP1692299A4 (en) QUICK PEPTIDOGLYCAN ASSAY FOR DETECTION OF BACTERIAL CONTAMINATION OF PLATELETS
FI990991A0 (en) Procedure for identifying an individual at risk of irreversible neurological damage